| GC31171-5mg |
|
109770-29-8 |
β-Amyloid 1-28 (Amyloid β-Protein (1-28))
|
0 |
C145H209N41O46 |
|
|
|
| GC31171-1mg |
|
109770-29-8 |
β-Amyloid 1-28 (Amyloid β-Protein (1-28))
|
0 |
C145H209N41O46 |
|
|
|
| GC31170-5mg |
|
115044-69-4 |
Calmodulin-Dependent Protein Kinase II 290-309
|
0 |
C103H185N31O24S |
|
|
|
| GC31170-1mg |
|
115044-69-4 |
Calmodulin-Dependent Protein Kinase II 290-309
|
0 |
C103H185N31O24S |
|
|
|
| GC31169-10mg |
|
79243-10-0 |
|
0 |
C61H105N23O21S |
|
|
|
| GC31169-5mg |
|
79243-10-0 |
|
0 |
C61H105N23O21S |
|
|
|
| GC31169-1mg |
|
79243-10-0 |
|
0 |
C61H105N23O21S |
|
|
|
| GC31168-25mg |
|
77614-16-5 |
|
0 |
C40H50N8O10 |
|
|
|
| GC31168-10mg |
|
77614-16-5 |
|
0 |
C40H50N8O10 |
|
|
|
| GC31168-5mg |
|
77614-16-5 |
|
0 |
C40H50N8O10 |
|
|
|
| GC31168-1mg |
|
77614-16-5 |
|
0 |
C40H50N8O10 |
|
|
|
| GC31167-10mg |
|
653573-60-5 |
Sodium Channel inhibitor 2
|
0 |
C26H25Cl2N3O |
|
|
|
| GC31167-5mg |
|
653573-60-5 |
Sodium Channel inhibitor 2
|
0 |
C26H25Cl2N3O |
|
|
|
| GC31167-1mg |
|
653573-60-5 |
Sodium Channel inhibitor 2
|
0 |
C26H25Cl2N3O |
|
|
|
| GC31166-10mg |
|
786701-13-1 |
|
0 |
C22H24N6O2 |
|
|
|
| GC31166-5mg |
|
786701-13-1 |
|
0 |
C22H24N6O2 |
|
|
|
| GC31166-1mg |
|
786701-13-1 |
|
0 |
C22H24N6O2 |
|
|
|
| GC31165-5mg |
|
90880-35-6 |
Neuropeptide Y (29-64), amide, human (Human neuropeptide Y (29-64))
|
0 |
C189H285N55O57S |
|
|
|
| GC31165-1mg |
|
90880-35-6 |
Neuropeptide Y (29-64), amide, human (Human neuropeptide Y (29-64))
|
0 |
C189H285N55O57S |
|
|
|
| GC31162-5mg |
|
1096485-24-3 |
|
0 |
C64H110N20O16 |
|
|
|
